JPH0587488B2 - - Google Patents

Info

Publication number
JPH0587488B2
JPH0587488B2 JP59268592A JP26859284A JPH0587488B2 JP H0587488 B2 JPH0587488 B2 JP H0587488B2 JP 59268592 A JP59268592 A JP 59268592A JP 26859284 A JP26859284 A JP 26859284A JP H0587488 B2 JPH0587488 B2 JP H0587488B2
Authority
JP
Japan
Prior art keywords
release
weight
cellulose
preparation
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP59268592A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61148115A (ja
Inventor
Takeshi Nara
Tokuo Hatori
Yozo Nishinomya
Hisashi Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toa Eiyo Ltd
Original Assignee
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd filed Critical Toa Eiyo Ltd
Priority to JP26859284A priority Critical patent/JPS61148115A/ja
Publication of JPS61148115A publication Critical patent/JPS61148115A/ja
Publication of JPH0587488B2 publication Critical patent/JPH0587488B2/ja
Granted legal-status Critical Current

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2210/00—Fluid
    • F04C2210/26—Refrigerants with particular properties, e.g. HFC-134a

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP26859284A 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法 Granted JPS61148115A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26859284A JPS61148115A (ja) 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26859284A JPS61148115A (ja) 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法

Publications (2)

Publication Number Publication Date
JPS61148115A JPS61148115A (ja) 1986-07-05
JPH0587488B2 true JPH0587488B2 (Sortimente) 1993-12-16

Family

ID=17460672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26859284A Granted JPS61148115A (ja) 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法

Country Status (1)

Country Link
JP (1) JPS61148115A (Sortimente)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
IT1213508B (it) * 1986-10-22 1989-12-20 Foscama Biomed Chim Farma Preparato farmaceutico a base di buflomedil cloridrato, sotto formadi compresse a rilascio controllato e relativo procedimento di preparazione.
JP2708803B2 (ja) * 1987-09-02 1998-02-04 中外製薬株式会社 持続放出製剤
TW209174B (Sortimente) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
GB9713549D0 (en) * 1996-10-18 1997-09-03 Euro Celtique Sa Pharmaceutical combination formulation
JP4696210B2 (ja) * 2000-06-07 2011-06-08 トーアエイヨー株式会社 イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
JP2005029523A (ja) * 2003-07-09 2005-02-03 Eisai Co Ltd 新規錠剤
CA2569968C (en) * 2004-06-10 2014-08-19 Glatt Air Techniques, Inc. Controlled release matrix pharmaceutical dosage formulation
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
WO2007026864A1 (ja) * 2005-09-01 2007-03-08 Eisai R & D Management Co., Ltd. 崩壊性の改善された医薬組成物の製造方法
EP3444363B1 (en) 2011-06-03 2020-11-25 Eisai R&D Management Co., Ltd. Biomarkers for prediciting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
CA2912219C (en) 2013-05-14 2021-11-16 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
KR102329681B1 (ko) 2014-08-28 2021-11-23 에자이 알앤드디 매니지먼트 가부시키가이샤 고순도의 퀴놀린 유도체 및 이를 제조하는 방법
DK3263106T3 (da) 2015-02-25 2024-01-08 Eisai R&D Man Co Ltd Fremgangsmåde til undertrykkelse af bitterhed af quinolinderivat
WO2016140717A1 (en) 2015-03-04 2016-09-09 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
WO2016204193A1 (ja) 2015-06-16 2016-12-22 株式会社ＰＲＩＳＭ Ｐｈａｒｍａ 抗がん剤
EP3338779B1 (en) 2015-08-20 2021-06-30 Eisai R&D Management Co., Ltd. Lenvatinib in combination with etoposide and ifosfamide for use in treating a tumor
US12303505B2 (en) 2017-02-08 2025-05-20 Eisai R&D Management Co., Ltd. Tumor-treating pharmaceutical composition
CA3061888A1 (en) 2017-05-16 2018-11-22 Eisai R&D Management Co., Ltd. Treatment of hepatocellular carcinoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58109412A (ja) * 1981-12-23 1983-06-29 Toa Eiyou Kagaku Kogyo Kk ニフエジピン固形製剤

Also Published As

Publication number Publication date
JPS61148115A (ja) 1986-07-05

Similar Documents

Publication Publication Date Title
RU2245148C2 (ru) Фармацевтическая композиция на основе месалазина для перорального введения с регулируемым высвобождением активного ингредиента
FI91482B (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
JPH0587488B2 (Sortimente)
EP0196700B1 (en) Devices for the controlled release of active substances, as well as process for the preparation thereof
DE69923200T2 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
US5051263A (en) Controlled-release formulations
CN102105136B (zh) 包含非-阿片类止痛剂和阿片类止痛剂的组合的胃滞留型缓释剂型
EP0120118B1 (en) Constant release rate solid oral dosage formulations of cardiovascular drugs
RU2235540C2 (ru) Способ получения пероральной препаративной формы пролонгированного действия с регулируемым высвобождением активного вещества в зависимости от вида и количества наполнения желудка и пищеварительного тракта
US4837032A (en) Theophylline sustained release tablet
JPH0122245B2 (Sortimente)
EP1293208A1 (en) Pharmaceutical formulation
US5234691A (en) Sustained-release prepararation of basic medical agent hydrochloride
WO2002043706A9 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
JPH09323926A (ja) バルプロ酸ナトリウムの徐放性錠剤
JPS62120315A (ja) 経口投与型徐放性錠剤の製造方法
CN115721600A (zh) 一种胃滞留型普瑞巴林缓释组合物及其制备方法
JP7650033B2 (ja) ニトロキソリンを含む医薬組成物、ニトロキソリン経口固形錠剤、その調製方法、及びその使用
CN112168796B (zh) 双相缓释系统控制释放的药物缓释制剂及其制备方法
CN114796134A (zh) 一种易于快速完全崩解的聚卡波非钙片剂
JPH04264021A (ja) 持続性錠剤
JPS6133007B2 (Sortimente)
KR100216624B1 (ko) 경구투여용 서방성 제제
KR100647901B1 (ko) 세파클러-함유 서방성 약제조성물 및 그의 제조방법
WO2024213341A1 (en) Sustained release dosage forms comprising complexes of low solutibility compounds, and methods for their preparation

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees